Di Wang, Hao-Ling Zhang, Hao-Long Zhang, Zhi-Jing Song, Sandai Doblin, Ping Lu
{"title":"Microbiota and cancer: Elucidating the role of <i>Candida albicans</i> in cancer progression.","authors":"Di Wang, Hao-Ling Zhang, Hao-Long Zhang, Zhi-Jing Song, Sandai Doblin, Ping Lu","doi":"10.5306/wjco.v16.i6.106847","DOIUrl":null,"url":null,"abstract":"<p><p><i>Candida albicans</i> (<i>C. albicans</i>) represents one of the most prevalent opportunistic fungal pathogens in cancer patients. Although the association between <i>C. albicans</i> and cancer has been recognized for decades, the causal relationship, whether <i>C. albicans</i> infection is a consequence of cancer or a direct contributor to cancer development-remains a subject of intensive investigation. Recently, the complex interplay between microbes and cancer has garnered significant attention within the scientific community, with growing interest in elucidating the underlying molecular mechanisms. This review systematically examines the biological characteristics of <i>C. albicans</i>, its multifaceted interactions with the host, and its relationship with the intestinal microbiota. Additionally, it provides a comprehensive analysis of the association between <i>C. albicans</i> and the development of various malignancies, with particular emphasis on digestive tract cancers. The review also identifies critical knowledge gaps and apparent contradictions in existing research, highlighting potential avenues for breakthroughs that will advance the efficient and accurate screening, diagnosis, and treatment of cancer.</p>","PeriodicalId":23802,"journal":{"name":"World journal of clinical oncology","volume":"16 6","pages":"106847"},"PeriodicalIF":3.2000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12198873/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5306/wjco.v16.i6.106847","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Candida albicans (C. albicans) represents one of the most prevalent opportunistic fungal pathogens in cancer patients. Although the association between C. albicans and cancer has been recognized for decades, the causal relationship, whether C. albicans infection is a consequence of cancer or a direct contributor to cancer development-remains a subject of intensive investigation. Recently, the complex interplay between microbes and cancer has garnered significant attention within the scientific community, with growing interest in elucidating the underlying molecular mechanisms. This review systematically examines the biological characteristics of C. albicans, its multifaceted interactions with the host, and its relationship with the intestinal microbiota. Additionally, it provides a comprehensive analysis of the association between C. albicans and the development of various malignancies, with particular emphasis on digestive tract cancers. The review also identifies critical knowledge gaps and apparent contradictions in existing research, highlighting potential avenues for breakthroughs that will advance the efficient and accurate screening, diagnosis, and treatment of cancer.
期刊介绍:
The WJCO is a high-quality, peer reviewed, open-access journal. The primary task of WJCO is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of oncology. In order to promote productive academic communication, the peer review process for the WJCO is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJCO are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in oncology. Scope: Art of Oncology, Biology of Neoplasia, Breast Cancer, Cancer Prevention and Control, Cancer-Related Complications, Diagnosis in Oncology, Gastrointestinal Cancer, Genetic Testing For Cancer, Gynecologic Cancer, Head and Neck Cancer, Hematologic Malignancy, Lung Cancer, Melanoma, Molecular Oncology, Neurooncology, Palliative and Supportive Care, Pediatric Oncology, Surgical Oncology, Translational Oncology, and Urologic Oncology.